adverse effects of amantadine
week
medication
reported side effects
nausea
dizziness/lightheadedness
insomnia
patients
side effects
involving
central nervous system
patients with renal dysfunction
advanced age
close monitoring for undue adverse effects
nervous system
side effects
dizziness/lightheadedness
insomnia
patients
hallucinations
confusion
ataxia
headache
somnolence
agitation
fatigue
patients
weakness
speech
hyperkinesia
patients
instances of convulsion
patients
case
head syndrome
unbalanced contraction of the neck muscles
neuroleptic malignant syndrome
involuntary muscle contractions
coma
stupor
hypokinesia
hypertonia
gait abnormalities
paresthesia
eeg changes
tremor
postmarketing experience
agitation
hallucinations
stupor
speech
abrupt discontinuation
most cases of cns toxicity
patients with renal insufficiency
seizure disorders
psychiatric illnesses
elderly patients
receiving mg/day for influenza prophylaxis
case report
psychotic episode
abnormal behavior in a young woman
week of concomitant therapy with naldecon
patient
family history of psychiatric illness
history of recreational substance use
episode
amantadine
phenylpropanolamine in the naldecon
interaction between the
exacerbation of panic
patient
weeks after the initiation of amantadine therapy for parkinson
disease
causal relationship
severe cns
adverse effects
dosages
amantadine blood levels
exceeding mcg/ml
most cases of cns toxicity
patients with renal insufficiency
seizure disorders
psychiatric illnesses
elderly patients
receiving mg/day for influenza prophylaxis
psychiatric side effects
depression
anxiety
irritability
nervousness
dream abnormality
patients
psychosis
euphoria
thinking abnormality
amnesia
libido
patients
suicidal attempt
suicidal ideation
suicide
patients
aggressive behavior
delirium
delusions
manic reaction
paranoid reaction
delusions of parasitosis
pathological gambling
libido
including hypersexuality
impulse control symptoms
postmarketing experience
delirium
delusions
paranoid reaction
anxiety
depression
abrupt discontinuation
gastrointestinal side effects
nausea
patients
diarrhea
constipation
anorexia
dry mouth
patients
vomiting
patients
dysphasia
postmarketing experience
cardiovascular
side effects
orthostatic hypotension
patients
congestive heart failure
hypertension
patients
cardiac arrest
arrhythmias
including
malignant arrhythmias
hypotension
tachycardia
postmarketing experience
congestive heart failure with severe lower limb edema
patient
receiving amantadine
resolved following drug discontinuation
positive correlation with amantadine therapy
other cause for this patient
heart failure
cases
decreased visual acuity
been reported following
weeks of amantadine therapy
drug discontinuation
case
visual disturbance
corneal edema
amiodarone
ocular side effects
visual disturbance
including punctuate
other corneal opacity
corneal edema
visual acuity
sensitivity
light
optic nerve palsy
patients
oculogyric episodes in less
patients
keratitis
mydriasis
postmarketing experience
other side effects
peripheral edema
edema
fever
postmarketing experience
respiratory side effects
dry nose
dyspnea
acute respiratory failure
pulmonary edema
tachypnea
postmarketing experience
hematologic side effects
leukopenia
neutropenia in less
patients
leukocytosis
agranulocytosis
postmarketing experience
livedo reticularis
legs
weeks
months
following drug discontinuation
dermatologic side effects
livedo reticularis
skin rash
eczematoid dermatitis
pruritus
diaphoresis
postmarketing experience
hypersensitivity side effects
allergic reactions
anaphylactic reactions
postmarketing experience
genitourinary side effects
urinary retention
renal side effects
elevations in bun
serum creatinine
postmarketing experience
hepatic side effects
elevations in bilirubin
ggt
sgot
sgpt
postmarketing experience
metabolic side effects
elevated alkaline phosphatase
lactate dehydrogenase
postmarketing experience
musculoskeletal side effects
elevated creatine kinase
postmarketing experience
year-old female patient with parkinson disease
syndrome of inappropriate antidiuretic hormone secretion
days
starting amantadine
entacapone
patient
following discontinuation of entacapone
days after entacapone
amantadine
patient
improved following amantadine discontinuation
endocrine side effects
case of syndrome of inappropriate antidiuretic hormone secretion
blurred vision
confusion
difficult urination
dizziness or lightheadedness
fainting
seeing
hearing
feeling things
swelling of the hands
feet
lower legs
convulsions (seizures)
decreased vision
change in vision
difficulty in coordination
fever
chills
sore throat
increased blood pressure
increase in body movements
irritation
swelling of the eye
loss of memory
mental depression
severe mood
mental changes
skin rash
slurred speech
thoughts of suicide
attempts at suicide
unexplained shortness of breath
agitation
anxiety
nervousness
difficulty concentrating
headache
irritability
loss of appetite
nausea
purplish red
blotchy spots on the skin
trouble
sleeping
nightmares
constipation
decrease in sexual desire
diarrhea
drowsiness
dryness of the mouth
nose
throat
false sense of well-being
vomiting
unusual tiredness
weakness